Dr. Gerhard Bauer is the director of the UC Davis Institute for Regenerative Cures’ Good Manufacturing Practice, also known as GMP. His practice in the field of cell and gene therapy and twenty year work for the application of these practices through clinical trials has had a tremendous impact upon the improvement of various medical conditions, which influence the lives of millions of people every day. Currently an assistant professor of oncology and hematology at UC Davis, Dr.Bauer arrived to join the team of the UC Davis Stem Cell Program in 2006, after designing a GMP facility at Washington University of St. Louis.

Native Austrian, Dr. Bauer graduated from a medical school in Vienna, later arriving to the United States, first to direct University of Maryland’s HIV research laboratory, then initiating a clinical stem cell gene therapy for HIV, and, in 1995, took a position in the Children’s Hospital of Los Angeles, amplifying the stem cell gene therapy clinical trials for transduction and cell processing procedures, concerning illnesses inflicting children.

Dr. Bauer has published ten works, concerning stem cells and their applications to neurological diseases; the immune system, immunization, gene therapy, and vector production. Collaborating with Dr. Nolta, they have been able to obtain Food and Drug Administration approval for a myriad of innovative stem cell treatments and therapies. Through the successful partnership with Dr. Bauer’s Good Manufacturing Practice facility, even more clinical trials concerning stem cells and their applications in the field of medicine gained authorization

(CITATIONS 67) (CITATIONS 68) (CITATIONS 69)